TREAT(ment) for man's best friend.
Despite significant advancements in human cancer therapeutics, canine oncological care lags far behind.
We intend to close that gap.
Vision
We are TREAT, a team founded by veterans in biotech with years of experience. Our mission is to translate human oncology drugs to the canine space. This is the space to introduce visitors to the business or brand. Briefly explain who's behind it, what it does, and what makes it unique. Share its core values and what this site has to offer.
Why We TREAT Canine Cancer
The high incidence of canine cancer and the ever-increasing cost of treatment compel us to create more effective, and affordable drugs for TREATing cancer.
1 in 4
One in four dogs will develop neoplasia (pre-cancer).
- American Veterinary Medical Association (AVMA)
50%
Half of all dogs over the age of 10 years will develop cancer.
- American Veterinary Medical Association (AVMA)
>$4,000
The average cost of a canine cancer treatment exceeds $4,000, despite these drugs being outdated.
- Pets Best database from 2017 to 2021
24.5M
Twenty-four and a half million dollars in claims were made by Nationwide pet insurance members last year on cancer-related conditions.
- Nationwide
Treat(ments) - Targetted Drug Therapies
Introducing veterinary medicine's first bispecific antibody immune checkpoint inhibitor: a first in veterinary medicine.
Novel Drug Discovery Powered by A.I.
Our cutting-edge technology harnesses the power of a groundbreaking A.I. system named A.I.Mee, revolutionizing the way we predict optimal targeting sites. Unlike any other system, A.I.Mee integrates tertiary and secondary structural data with biochemical information to flawlessly AIM for our drug targets with unparalleled accuracy and precision.
Monoclonal Antibody
These unique antibodies are designed to mimic the immune system's ability to fight off harmful pathogens or abnormal cells.
Short Peptide
Our short peptide therapies involve the use of small amino acid chains of amino acids, known as peptides, to regulate various biological processes.
Small Molecule
Because of their low molecular weight, small molecule compounds can easily penetrate cell membranes to reach its target.